| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Halfpenny Technologies, Inc. provides clinical labs, hospitals, accountable care organizations (ACOs), health plans, health information exchanges (HIEs) and EHR vendors with a cloud-based, secure, scalable and vendor-neutral clinical data exchange platform designed to optimize patient care coordination while reducing waste. We have a long-standing, proven track record of providing advanced features, rapid implementation, reliable technology infrastructure and LOINC mapping that enables laboratories and hospitals to win new accounts and improve service to existing clients
Giant Steps Therapeutic Equestrian Center Inc is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Araceli Biosciences is a company that develops scientific instrumentation to improve outcomes in tissue and cell based biomarker discovery, drug discovery and drug development.
integrated medical partners is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Mequon, WI. To find more information about integrated medical partners, please visit www.integratedmp.com